The transition of LiDCO from a razor/razor blade model into a SaaS operating model, selling High Usage Programme (HUP) hemodynamic monitors, continues, albeit the sales cycle remains a long one. Three new US HUP wins announced today (21 monitors) takes H1 customer wins to five and seven in total, with scope for these hospitals to build their HUP installed base given their sizes. First half revenues are 8% lower than last year, affected by lower third-party revenues and less capital sales as c
20 Aug 2018
LiDCO - Interim trading update and HUP progress
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LiDCO - Interim trading update and HUP progress
- Published:
20 Aug 2018 -
Author:
Mark Brewer -
Pages:
6
The transition of LiDCO from a razor/razor blade model into a SaaS operating model, selling High Usage Programme (HUP) hemodynamic monitors, continues, albeit the sales cycle remains a long one. Three new US HUP wins announced today (21 monitors) takes H1 customer wins to five and seven in total, with scope for these hospitals to build their HUP installed base given their sizes. First half revenues are 8% lower than last year, affected by lower third-party revenues and less capital sales as c